Φορτώνει......
Designing tuberculosis vaccine efficacy trials – lessons from recent studies
Introduction: Tuberculosis (TB) is the leading infectious killer globally and new TB vaccines will be crucial to ending the epidemic. Since the introduction in 1921 of the only currently licensed TB vaccine, BCG, very few novel vaccine candidates or strategies have advanced into clinical efficacy tr...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Expert Rev Vaccines |
|---|---|
| Κύριος συγγραφέας: | |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Taylor & Francis
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6492041/ https://ncbi.nlm.nih.gov/pubmed/30892969 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14760584.2019.1593143 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|